Immune Responses in Oncology Patients to Novel Coronavirus Vaccines (IROC)

NCT04930055 · clinicaltrials.gov ↗
TERMINATED
Status
2206
Enrollment
OTHER
Sponsor class

Stopped PI had decided to terminate the study

Conditions

Interventions

Sponsor

Indiana University